Epithelial to Mesenchymal Transition Tumors: Fallacious or Snail's Pace?

Abstract excerpt

In this issue of Clinical Cancer Research , Yauch et al. ([1][1]) present evidence that a subset of non–small cell lung carcinomas that do not respond to erlotinib therapy have low levels of E-cadherin and higher levels of mesenchymal-type transcripts. The bulk of their evidence uses non–small

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Lung Cancer Research Studies
• Share to Lung Cancer Treatments and Mutations
• Share to RNA modifications and cancer